Medicamentos de actualidad = Drugs of today

• 

  Año 2019, Vol. 55, Número 3

  • MONOGRAPHS

    • Ertugliflozin for the treatment of type 2 diabetes.

      Raman Sharma, Karan Razdan, Anurag Kuhad, Astha Kuhad

      • Resumen

      págs. 167-175

      

    • Cannabidiol as adjunctive treatment of seizures associated with Lennox–Gastaut syndrome and Dravet syndrome.

      Simona Lattanzi, Eugen Trinka, Emilio Russo, Pasquale Striano, Rita Citraro, Mauro Silvestrini, Francesco Brigo

      • Resumen

      págs. 177-196

      

  • REVIEWS

    • Dual versus triple antithrombotic therapy: is there a role for direct oral anticoagulants in arterial thrombosis?

      Álvaro García Ropero, Carlos G. Santos Gallego, Mohammad Urooj Zafar, Juan José Badimón

      • Resumen

      págs. 197-214

      

    • Management of multidrug-resistant tuberculosis in the 21st century

      Grace Kaul, E. Kapoor, Arunava Dasgupta, Sidharth Chopra

      • Resumen

      págs. 215-224

      

  • NEW PRODUCT INTROS

    • New product intros [emapalumab-lzsg, lamivudine/tenofovir disoproxil fumarate (new combination), levodopa (new formulation), relugolix, romosozumab, sintilimab, sodium zirconium cyclosilicate].

      pág. 225